Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Reuters

17:21 EDT 21st April 2018 | BioPortfolio

Here are the most relevant search results for "Reuters" found in our extensive news archives from over 250 global news sources.

More Information about Reuters on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reuters for you to read. Along with our medical data and news we also list Reuters Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reuters Companies for you to search.

Showing News Articles 1–25 of 2,800+ from Reuters

Friday 20th April 2018

Many approaches may help children improve self-regulation

(Reuters Health) - Yoga, exercise, education and personal skills training are among the many types of interventions that may help kids improve what's known as self-regulation, or their ability to manage their behavior and emotions, a study suggests. ...

Opioids overprescribed to patients taking certain sedatives

(Reuters Health) - Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but a study suggests doctors are still over-prescribing this combination of medicines.

Hungarian laboratory worker isolated after exposure to Ebola virus

BUDAPEST (Reuters) - A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly Ebola virus but has shown no symptoms so far, health officials said on Friday.

Losing a spouse late in life linked to cognitive decline

(Reuters Health) - Older adults who lose a spouse may be more vulnerable to cognitive decline in subsequent years and require extra support and monitoring, researchers say.

Many U.S. kids with brain injuries not getting needed rehab

(Reuters Health) - Many children hospitalized in the U.S. for brain injuries don't receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.

Germany's Merck seeks partners for cancer and immune system drugs

FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.

Biogen boosts investment in neurology with $1 billion Ionis deal

(Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.

Thursday 19th April 2018

U.S. appeals court blocks Indiana 'selective' abortion law

(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses...

Improving overall heart health may reduce risk of atrial fibrillation

(Reuters Health) - Following practices recommended for "optimal" heart health may also reduce the risk of developing a serious heart-rhythm disorder, researchers say.

GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval

(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.

WHO recommends more tests for Sanofi's dengue vaccine

PARIS/CHICAGO (Reuters) - The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.

Large spleen helps explain deep-diving skills of Southeast Asian 'sea nomads'

(Reuters Health) - An age-old nomadic community of Southeast Asian boat-dwellers who get their food from the sea appear to have evolved enlarged spleens that may help explain their extreme diving prowess, a new study suggests.

Concussion raises Parkinson's disease risk in large U.S. study

(Reuters Health) - A new study of hundreds of thousands of U.S. armed forces veterans concludes that banging your head severely enough to lose consciousness can dramatically increase the risk of Parkinson's, the brain disease marked by tremors, slow ...

"Play outside": Belgium tells kids to leave TV for sun and games

BRUSSELS (Reuters) - No television and no tablets. It sounds like a punishment, but across Belgium it was the recipe for the nationwide children's "play outside" day.

FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug

(Reuters) - The U.S. Food and Drug Administration staff on Thursday flagged concerns about potentially fatal blood clots from higher doses of Eli Lilly and Co and Incyte Corp's rheumatoid arthritis drug.

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.

FDA panel unanimously backs GW Pharma's cannabis-based epilepsy drug

(Reuters) - GW Pharmaceuticals Plc's cannabis-derived drug to treat a severe form of childhood epilepsy was unanimously backed on Thursday by an advisory panel to the U.S. Food and Drug Administration.

WHO recommends testing before use of Sanofi's dengue vaccine

PARIS (Reuters) - The World Health Organisation on Thursday said Sanofi's vaccine against dengue should only be used after testing individuals to assess whether they could have been exposed before to the infection.

More than half of world's wealthy expect to live to 100 :survey

LONDON (Reuters) - More than half of wealthy investors around the world expect to live to the age of 100, with almost two in three planning to work longer in life to afford a comfortable retirement, according to a survey on Thursday.

Wednesday 18th April 2018

AstraZeneca wins U.S. approval for 1st-line use of lung cancer drug

(Reuters) - U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.

Later middle school start times tied to longer sleep for kids

(Reuters Health) - Starting middle school classes after 8 a.m. could help pre-teens get more sleep and be more awake during their morning lessons, a U.S. study suggests.

AstraZeneca wins U.S. FDA approval for first-line use of lung cancer drug

(Reuters) - AstraZeneca Plc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved the 1st-line use of its lung cancer drug, Tagrisso.

AI pharma firm BenevolentAI raises $115 million in funding

LONDON (Reuters) - BenevolentAI, a British pharmaceutical company that uses artificial intelligence to identify new drug candidates, said it had raised $115 million in a funding round that valued it at $2 billion. 

U.S. appeals court says Ohio cannot block Planned Parenthood funds

(Reuters) - A federal appeals court on Wednesday blocked an Ohio law that would cut federal taxpayer funding to 28 Planned Parenthood clinics, holding that it imposed unconstitutional conditions by denying funds to abortion providers.

Malawi can eradicate HIV infections says U.S. doctor who discovered AIDS virus

BLANTYRE (Reuters) - Malawi, which has one of the highest rates of the deadly HIV/AIDS infections, is on course to eradicate the virus, Jay Levy who co-discovered the AIDS virus 35 years ago said.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks